CONVERSION OF TREATMENT FROM CEFOXITIN TO AMPICILLIN-SULBACTAM - EXPERIENCE IN A UNIVERSITY TEACHING HOSPITAL

Authors
KITRENOS JG ROTELLA DL NAKASATO S
Citation
Jg. Kitrenos et al., CONVERSION OF TREATMENT FROM CEFOXITIN TO AMPICILLIN-SULBACTAM - EXPERIENCE IN A UNIVERSITY TEACHING HOSPITAL, Advances in therapy, 12(1), 1995, pp. 30-43
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental","Pharmacology & Pharmacy
Journal title
Advances in therapy → ACNP
ISSN journal
0741238X
Volume
12
Issue
1
Year of publication
1995
Pages
30 - 43
Database
ISI
SICI code
0741-238X(1995)12:1<30:COTFCT>2.0.ZU;2-C
Abstract
A 12-month trial, conducted in a 650-bed university teaching hospital, evaluated the conversion from cefoxitin to ampicillin/sulbactam. This report discusses the methodology used to evaluate the feasibility of the change and the challenges encountered during the trial period. The effect of cost and overall therapeutic outcome were other aspects of the evaluation. Results indicate that a conversion from cefoxitin to a mpicillin/sulbactam is not only feasible but is also a realistic appro ach to achieving high-quality, cost-effective care.